BIOGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 218.9 USD | -1.13% |
|
+1.91% | -15.40% |
| May. 07 | FDA Sets June 10 Advisory Panel Meeting on Eli Lilly Alzheimer's Drug | DJ |
| May. 06 | People with two copies of a risk gene have genetic form of Alzheimer's, scientists say | RE |
ETFs positioned on Biogen Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.21% | 0 M€ | +0.87% | - | |
| 0.21% | 0 M€ | +4.68% | - | |
| 0.20% | 219 M€ | +17.17% | - | |
| 0.20% | 1,448 M€ | -.--% | - | |
| 0.20% | 0 M€ | +8.81% | ||
| 0.20% | 330 M€ | -.--% | - | |
| 0.20% | 2 M€ | +14.69% | - | |
| 0.18% | 0 M€ | +17.41% | - | |
| 0.18% | 0 M€ | +4.91% | - | |
| 0.18% | 0 M€ | +8.32% | ||
| 0.18% | 276 M€ | +11.40% | - | |
| 0.18% | 1,174 M€ | +23.54% | ||
| 0.18% | 655 M€ | -.--% | - | |
| 0.18% | 273 M€ | -.--% | ||
| 0.17% | 36 M€ | +22.19% | ||
| 0.17% | 0 M€ | +6.86% | ||
| 0.16% | 0 M€ | +18.29% | - | |
| 0.15% | 0 M€ | +12.66% | ||
| 0.14% | 1,848 M€ | +18.39% | - | |
| 0.14% | 559 M€ | +14.30% | - | |
| 0.13% | 1 M€ | +0.04% | ||
| 0.12% | 6 M€ | +17.98% | - | |
| 0.12% | 0 M€ | +6.24% | - | |
| 0.12% | 0 M€ | +2.82% | - | |
| 0.12% | 0 M€ | +4.04% | - | |
| 0.12% | 205 M€ | -.--% | ||
| 0.11% | 0 M€ | +18.67% | - | |
| 0.10% | 0 M€ | -.--% | - | |
| 0.10% | 0 M€ | +8.83% | - | |
| 0.10% | 0 M€ | +11.24% |
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
218.9
USD
Average target price
285.9
USD
Spread / Average Target
+30.61%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.40% | 31.87B | |
| -2.35% | 89.33B | |
| +3.29% | 41.19B | |
| +52.60% | 24.52B | |
| -14.35% | 15.68B | |
| -39.65% | 12.23B | |
| -6.52% | 12.34B | |
| -13.41% | 12.21B | |
| +5.24% | 8.83B | |
| -6.43% | 8.28B |
- Stock Market
- Equities
- BIIB Stock
- Funds and ETFs Biogen Inc.